Table 3.
Characteristics | Positive | Negative |
---|---|---|
Total | 80 | 50 |
FIGO 2014 Stage | ||
I | 18 | 2 |
II | 12 | 1 |
III | 45 | 26 |
IIIa | 5 | 0 |
IIIb | 13 | 3 |
IIIc | 27 | 23 |
IV | 5 | 21 |
Early (I/II) stage-%(95% CI) | 37.5 (26.9, 49.0) | 6.0 (1.3, 16.6) |
Morphology | ||
Type I iEOC (total) | 15 (18.8%) | 1 (2.0%) |
Low grade serous | 3 | 0 |
Endometrioid (low grade) | 3 | 0 |
Clear cell | 6 | 0 |
Mucinous | 3 | 1 |
Type II iEOC (total) | 64 (80.0%) | 42 (84.0%) |
High grade serous | 53 | 36 |
High grade endometrioid | 4 | 0 |
Carcinoma | 4 | 6 |
Carcinosarcoma | 3 | 0 |
Unclassified * | 1 (1.3%) | 7 (14.0%) |
Date are numbers unless otherwise stated. * Morphology could not be determined as only peritoneal fluid cytology was undertaken.